PRL and breast cancer: Accordingly, the restoration/activation of prolactin/PRLR signaling has been shown to promote cell differentiation and reverse highly proliferative, invasive, mesenchymal and tumorigenic phenotypes, such as those of the ER/PR double-negative MDA-MB-231 breast cancer model [107].